Sponsor

Eupraxia Pharmaceuticals Inc.

2198 Yukon Street, V5Y 3P1

About the sponsor

Eupraxia Pharmaceuticals Inc. focuses its clinical research on eosinophilic esophagitis, a chronic inflammatory disorder affecting the esophagus and swallowing function.

Eosinophilic esophagitis
Esophageal inflammation
Swallowing-related disease burden

The sponsor’s research activity is centered on an adult population with symptomatic esophageal disease and histologic measures of tissue involvement.

About Specializations

Eupraxia Pharmaceuticals Inc. runs clinical trials in conditions such as Eosinophilic oesophagitis, among others.

Eosinophilic oesophagitis

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Eosinophilic oesophagitis

Not recruiting

Study on the Effects of EP-104IAR and Tetracosactide for Adults with Eosinophilic Esophagitis

Registered drugNo placebo

Study on the Effects of EP-104IAR and Tetracosactide for Adults with Eosinophilic Esophagitis

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Tetracosactide
Sponsor:Eupraxia Pharmaceuticals Inc.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →

About the sponsor

About Specializations

Ongoing trials

1 clinical trial

Eosinophilic oesophagitis

Study on the Effects of EP-104IAR and Tetracosactide for Adults with Eosinophilic Esophagitis

Are you running a clinical trial?

Prefer not to search? Our Concierge searches the trials for you.